Fluarix Tetra 2025/2026 NH Vaccine (Vaccination at Home)

What is Fluarix Tetra 2025/2026 NH Vaccine? 

The Fluarix Tetra 2025/2026 NH Vaccine is a quadrivalent influenza vaccine formulated for the Northern Hemisphere (NH) 2025–2026 influenza season. It contains inactivated virus strains from four influenza types: two Type A strains (H1N1 and H3N2) and two Type B strains (Victoria and Yamagata lineages). This vaccine works by stimulating the immune system to produce protective antibodies against the influenza virus. It is essential to take the vaccine doses per the doctor for adequate protection against the disease.

Who should get vaccinated?

Fluarix Tetra 2025/2026 NH Vaccine is recommended for adults and children aged 6 months and above as an annual preventive measure against influenza infection.

Administration (For Adults only):

It will be administered by a qualified healthcare professional. Kindly do not self-administer. Annual revaccination with Fluarix Tetra 2025/2026 NH Vaccine is recommended given the duration of immunity provided by the vaccine and because circulating strains of the influenza virus might change from year to year.  

Benefits of the Fluarix Tetra 2025/2026 NH Vaccine:

• Provides broad protection against four major influenza strains (including seasonal and swine flu)
• Lowers the risk of flu-related complications 
• Helps prevent community transmission of the flu virus
• Reduces the severity and duration of flu symptoms if infection occurs